Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. (Q47933212)

6 February 2018

title

Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. (English)

1 reference

6 February 2018

Sabine Rakotobe

4

0 references

Laurent Dubuquoy

Laurent Dubuquoy

1

0 references

Pierre Desreumaux

Pierre Desreumaux

9

0 references

Johan Auwerx

7

Johan Auwerx

1 reference

PubMed ID

12730867

6 February 2018

Jean-Frédéric Colombel

6

Jean-Frédéric Colombel

1 reference

6 February 2018

author name string

Emmelie A Jansson

2

1 reference

6 February 2018

Samir Deeb

3

1 reference

6 February 2018

Mehdi Karoui

5

1 reference

6 February 2018

Sven Pettersson

8

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 February 2018

published in

Gastroenterology

1 reference

6 February 2018

volume

124

1 reference

6 February 2018

page(s)

1265-1276

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

Peroxisome proliterator-activated receptors, orphans with ligands and functions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

NF-kappaB: a key role in inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

The epidemiology and the pathogenesis of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Bacteria as the cause of ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

A peptide derived from bovine beta-casein modulates functional properties of bone marrow-derived macrophages from germfree and human flora-associated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Differential diagnosis of inflammatory bowel disease. A comparison of various diagnostic classifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

An easy method of layering blood over Ficoll-Paque gradients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Inflammatory alterations in mesenteric adipose tissue in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

The half-life of immunoglobulin mRNA increases during B-cell differentiation: a possible role for targeting to membrane-bound polysomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

The organization, promoter analysis, and expression of the human PPARgamma gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900271-3

10.1016/S0016-5085(03)00271-3

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

release_2pppg72rozbrzekcmj424qwrm4

Fatcat ID

0 references

PubMed ID

12730867

1 reference

6 February 2018